Sugar Amplifies Antibiotic Damage to Your Gut Microbiome, Study Finds
New research links higher sugar intake during antibiotic use to a 21% greater drop in gut bacterial diversity and dangerous bacterial overgrowth.
Summary
A large study tracking over 9,400 meals from 173 hospitalized cancer patients found that eating more sugar while taking antibiotics significantly worsens harm to the gut microbiome. For every extra 100 grams of sugar consumed in the 48 hours before antibiotic treatment, gut bacterial diversity dropped by an additional 21%. Sugary diets combined with antibiotics were also linked to dangerous overgrowth of Enterococcus faecium, a hard-to-treat bacterium. Mouse experiments confirmed the effect, showing a 33-fold increase in Enterococcus by day six. Researchers suggest that simply cutting back on sweets during and after antibiotic courses could help protect gut health, though clinical trials are still needed to confirm this as a formal recommendation.
Detailed Summary
The gut microbiome — the vast ecosystem of bacteria supporting digestion, immunity, and overall health — is notoriously vulnerable to antibiotics. New research published in Nature reveals that dietary sugar may be quietly making that damage far worse, offering a simple, actionable lever for people trying to protect their long-term gut health.
Researchers from NYU Langone Health, City of Hope, and Memorial Sloan Kettering tracked more than 9,400 meals eaten by 173 hospitalized blood cancer patients and collected daily microbiome samples. For every additional 100 grams of sugar consumed in the 48 hours before antibiotic treatment, alpha diversity — a key measure of beneficial bacterial variety — fell by an additional 21%. A diverse microbiome is strongly associated with resilience against infection and better long-term health outcomes.
Beyond diversity loss, sugary diets combined with antibiotics were linked to surges in Enterococcus faecium, a bacterium notorious for causing difficult-to-treat infections. Mouse experiments mirrored these findings dramatically: animals given antibiotics alongside dietary sucrose showed a 16.3-fold rise in gut Enterococcus by day three and a 33.4-fold increase by day six, underscoring just how rapidly sugar can tilt the microbial balance toward harmful species.
The study is particularly compelling because of its scale and detail. Researchers recorded every meal and collected daily biological samples, making it one of the most granular diet-microbiome studies conducted in a clinical setting. Blood cancer patients were chosen partly because they receive frequent antibiotic courses and their hospital meals can be precisely monitored.
The practical implication is straightforward: reducing sugar intake during and shortly after an antibiotic course may help preserve beneficial bacteria and limit the window of vulnerability to dangerous pathogens. Clinical trials are still needed to confirm this recommendation formally, and the findings may not translate identically to healthy adults outside a hospital setting.
Key Findings
- Each extra 100g of sugar consumed before antibiotics was linked to a 21% additional drop in gut bacterial diversity.
- Sugary diets plus antibiotics were associated with overgrowth of hard-to-treat Enterococcus faecium in cancer patients.
- In mice, antibiotic plus sucrose exposure drove a 33-fold increase in gut Enterococcus by day six.
- Cutting back on sweets during and after antibiotic treatment may help protect the gut microbiome.
- The study tracked over 9,400 meals from 173 patients, making it one of the largest diet-microbiome studies of its kind.
Methodology
This is a research summary based on a study published in Nature on September 30, 2026, from NYU Langone Health, City of Hope, and Memorial Sloan Kettering — high-credibility institutions. Evidence combines a large observational human cohort (173 patients, 9,400+ meals) with mechanistic mouse experiments, strengthening causal plausibility, though human causality remains to be confirmed by randomized trials.
Study Limitations
The human cohort consisted of hospitalized blood cancer patients receiving intensive treatment, so results may not directly generalize to healthy adults using antibiotics in outpatient settings. The study is observational in humans, so causality cannot be fully established without randomized controlled trials. The specific sugar thresholds and timing recommendations require further clinical validation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: